Aliskiren and Quinapril interaction

Aliskiren and Quinapril: both prescribing labels flag this combination with the strongest language, such as a contraindication, a boxed warning, or an instruction to avoid it.

Major

Do not combine without a prescriber's guidance. The label language below is the strongest FDA uses.

What the FDA labels say

From the Aliskiren label · effective 2022-12-30

Major

Do not use with angiotensin receptor blockers (ARBs) or angiotensin-converting enzyme inhibitors (ACEIs) in patients with diabetes.

Contraindicationsby drug classView label on DailyMed
Major

In general, avoid combined use of aliskiren with ACE inhibitors or ARBs, particularly in patients with creatinine clearance (CrCl) less than 60 mL/min [see Contraindications (4) , Drug Interactions (7) and Clinical Studies (14.3) ] .

Warnings and precautionsby drug classView label on DailyMed
Major

In general, avoid combined use of aliskiren with ACE inhibitors or ARBs, particularly in patients with CrCl less than 60 mL/min.

Drug interactionsby drug classView label on DailyMed

From the Quinapril label · effective 2024-05-15

Major

Do not co-administer quinapril tablets with aliskiren in patients with diabetes.

Contraindicationsnames AliskirenView label on DailyMed
Major

Do not co-administer aliskiren with quinapril hydrochloride in patients with diabetes.

Drug interactionsnames AliskirenView label on DailyMed
Major

Avoid concomitant use of aliskiren with quinapril hydrochloride in patients with renal impairment (GFR<60 mL/min/1.73 m 2 ).

Drug interactionsnames AliskirenView label on DailyMed
Moderate

Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy.

Drug interactionsnames AliskirenView label on DailyMed
Minor

Most epidemiologic studies examining fetal abnormalities after exposure to antihypertensive use in the first trimester have not distinguished drugs affecting the renin-angiotensin system from other antihypertensive agents.

Warningsby drug classView label on DailyMed

Taking more than these two? Interactions stack. Check your whole list at once; it stays in your browser.

Open in the checker

Not medical advice. Interaction Checker quotes FDA label text and NIH fact sheets. Whether an interaction matters for you depends on doses, timing, kidney and liver function, and other conditions. Confirm with a pharmacist or prescriber.